Table 2. Multivariable Cox proportional hazard models of RFS and OS.
Variable (contrast) |
Recurrence-free survival
|
Overall survival
|
||
---|---|---|---|---|
Hazard ratio | P-value | Hazard ratio | P-value | |
Number of positive nodes (sqrt) | 2.17 (1.82, 2.60) | <0.0001 | 2.18 (1.82, 2.63) | <0.0001 |
Menopausal status (pre/post) | 0.91 (0.75, 1.10) | 0.3276 | 0.88 (0.72, 1.08) | 0.2284 |
Dose density (q3wk/q2wk) | 1.20 (0.99, 1.45) | 0.0582 | 1.15 (0.94, 1.40) | 0.1671 |
Sequence of therapy (con/seq) | 0.98 (0.81, 1.18) | 0.8314 | 0.98 (0.80, 1.19) | 0.8174 |
| ||||
PAM50 intrinsic subtype
| ||||
Basal-like versus LumA | 1.83 (1.40, 2.38) | <0.0001 | 1.91 (1.44, 2.53) | <0.0001 |
HER2-E versus LumA | 1.63 (1.24, 2.15) | 1.69 (1.27, 2.26) | ||
LumB versus LumA | 1.47 (1.14, 1.91) | 1.47 (1.12, 1.94) |
Abbreviations: con, concurrent; HER2-E, HER2-enriched; Lum, luminal; q2wk, every two weeks or 2-weekly; q3wk, every 3 weeks or 3-weekly; seq, sequential; sqrt, square root.
N=1,299 because 11 patients were missing information about the number of positive nodes or menopausal status.